Related references
Note: Only part of the references are listed.T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells
Karol Granados et al.
BRITISH JOURNAL OF CANCER (2020)
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
Sandra Munoz-Galvan et al.
MOLECULAR CANCER (2020)
Current Molecular Markers of Melanoma and Treatment Targets
Kevin Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
BRN2 expression increases anoikis resistance in melanoma
Carly J. Pierce et al.
ONCOGENESIS (2020)
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
Aniello Federico et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer
Zachary A. Yochum et al.
ONCOGENE (2019)
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target
Elias Orouji et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance
Lionel Larribere et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter
Chao Huang et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Plasticity of Drug-Naive and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program
Malgorzata Czyz et al.
JOURNAL OF ONCOLOGY (2019)
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Victoria E. Wang et al.
CLINICAL CANCER RESEARCH (2019)
Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability
Alice Raineri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Connective tissue growth factor is correlated with peritoneal lymphangiogenesis
Hiroshi Kinashi et al.
SCIENTIFIC REPORTS (2019)
FOXD1 and Gal-3 Form a Positive Regulatory Loop to Regulate Lung Cancer Aggressiveness
Chien-Hsiu Li et al.
CANCERS (2019)
The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma
Ming Tan et al.
MOLECULAR ONCOLOGY (2019)
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells
Anna Laurenzana et al.
EBIOMEDICINE (2019)
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma
Laura Hueser et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
CTGF/VEGFA-activated Fibroblasts Promote Tumor Migration Through Micro-environmental Modulation
Wei Wu et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Yuan-Chin Tsai et al.
MOLECULAR CANCER (2018)
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation
Huizi Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation
Ole Jorgen Kaasboll et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
Sunilkumar Kakadia et al.
ONCOTARGETS AND THERAPY (2018)
New role of ID3 in melanoma adaptive drug-resistance
Sachindra et al.
ONCOTARGET (2017)
SOX10-MITF pathway activity in melanoma cells
Karol B. Tudrej et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
Potential therapeutic targets of epithelial mesenchymal transition in melanoma
Ross L. Pearlman et al.
CANCER LETTERS (2017)
Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
Min Hwan Kim et al.
EMBO JOURNAL (2016)
FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells
Peng Cheng et al.
CANCER RESEARCH (2016)
Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
Hanna Drzewiecka et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
Silvana Sandri et al.
PHARMACOLOGICAL RESEARCH (2016)
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers
Hiroto Hatakeyama et al.
CELL REPORTS (2016)
Resistant mechanisms to BRAF inhibitors in melanoma
Jose Luis Manzano et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27
Yi-Fan Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The role of melanin pigment in melanoma
Radomir M. Slominski et al.
EXPERIMENTAL DERMATOLOGY (2015)
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma
Nikolaus B. Wagner et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models
Rasmi R. Mishra et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2014)
Neural crest stem cells in melanoma development
Olga Shakhova
CURRENT OPINION IN ONCOLOGY (2014)
Regulation of pancreatic inflammation by connective tissue growth factor (CTGF/CCN2)
Alyssa Charrier et al.
IMMUNOLOGY (2014)
Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib
Jaime Acquaviva et al.
MOLECULAR CANCER THERAPEUTICS (2014)
CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma
Hsiao-Chi Tsai et al.
PLOS ONE (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
Foxd1 is a mediator and indicator of the cell reprogramming process
Makito Koga et al.
NATURE COMMUNICATIONS (2014)
Resistance to BRAF-targeted therapy in melanoma
Ryan J. Sullivan et al.
EUROPEAN JOURNAL OF CANCER (2013)
A Dual Role for SOX10 in the Maintenance of the Postnatal Melanocyte Lineage and the Differentiation of Melanocyte Stem Cell Progenitors
Melissa L. Harris et al.
PLOS GENETICS (2013)
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Kenneth E. Lipson et al.
FIBROGENESIS & TISSUE REPAIR (2012)
CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration
S. Braig et al.
BRITISH JOURNAL OF CANCER (2011)
A picture of Mitf in melanoma immortality
C. R. Goding
ONCOGENE (2011)
Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme
Dong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
PAX3 and SOX10 activate MET receptor expression in melanoma
Joseph B. Mascarenhas et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1
Ming-Yang Wang et al.
CANCER RESEARCH (2009)
The making of a melanocyte: the specification of melanoblasts from the neural crest
Aaron J. Thomas et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
CTGF enhances the motility of breast cancer cells via an integrin-αvβ3-ERK1/2-dependent S100A4-upregulated pathway
Pai-Sheng Chen et al.
JOURNAL OF CELL SCIENCE (2007)
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Suzanne Carreira et al.
GENES & DEVELOPMENT (2006)
Interspecies difference in the regulation of melanocyte development by SOX10 and MITF
Ling Hou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Melanocytes and the Microphthalmia transcription factor network
E Steingrimsson et al.
ANNUAL REVIEW OF GENETICS (2004)
Melanin pigmentation in mammalian skin and its hormonal regulation
A Slominski et al.
PHYSIOLOGICAL REVIEWS (2004)
Share Paper
